TREATMENT INTENSITY, INTENSIFICATION, AND CLINICAL OUTCOMES AMONG MEDICARE BENEFICIARIES WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2020)
摘要
Guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) recommends renin-angiotensin-aldosterone system (RAAS) inhibitors with beta blockers (BB), plus aldosterone antagonists (MRA) if symptoms persist. Clinical trials have shown that combination treatments
更多查看译文
关键词
heart failure,medicare beneficiaries,clinical outcomes,intensification
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要